ETFMG Treatments Testing and Adv ETF Stock Price, News & Analysis
GERM
NYSE
Company Description
ETFMG Treatments Testing and Adv ETF (NYSE: GERM) is a publicly traded company.
GERM stock has declined 1.4% over the past year. Shares last traded at $16.76.
This page provides a comprehensive overview of GERM stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
$—
0.00%
0.00
Last updated:
-1.35%
Performance 1 year
$0.0
600.0K
ETFMG Treatments Testing and Adv ETF (GERM) stock last traded at $16.76. Over the past 12 months, the stock has lost 1.4%.
Latest News
ETFMG Treatments Testing and Adv ETF has 1 recent news article. Of the recent coverage, 1 article coincided with positive price movement and 0 with negative movement. View all GERM news →
SEC Filings
Financial Highlights
—
Revenue (TTM)
—
Net Income (TTM)
—
Operating Cash Flow
Upcoming Events
Short Interest History
Last 12 Months
Days to Cover History
Last 12 Months
Frequently Asked Questions
What is the current stock price of ETFMG Treatments Testing and Adv ETF (GERM)?
The current stock price of ETFMG Treatments Testing and Adv ETF (GERM) is $16.7585 as of February 7, 2025.